A Study in Patients With Advanced Parkinson's Disease to Assess the Relative Bioavailability of Levodopa Administered as ND0612 Subcutaneous Infusion Versus Levodopa Administered as Carbidopa-Levodopa Enteral Suspension
Clinical trial NCT03462043 · WITHDRAWN
Trial details
- NCT number
- NCT03462043
- Sponsor
- NeuroDerm Ltd.
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-10
- Primary completion
- 2018-11-20
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.